PATH-03. CLINICAL UTILITY OF NEXT GENERATION SEQUENCING IN IDH-WILDTYPE GLIOBLASTOMA: THE DANA-FARBER CANCER INSTITUTE EXPERIENCE

BACKGROUND: Comprehensive next generation sequencing (NGS) is available through many academic institutions and commercial entities, and is incorporated in practice guidelines for glioblastoma (GBM). We retrospective evaluated the practice patterns and utility of incorporating NGS data into routine c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Jane Lim-Fat, Mary, Youssef, Gilbert, Touat, Mehdi, Iorgulescu, Bryan, Woodward, Eleanor, Whorral, Sydney, Allen, Marie, Vogelzang, Jayne, Pisano, William, Rahman, Rifaquat, Chukwueke, Ugonma, Mcfaline-Figueroa, Jose, Nayak, Lakshmi, Lee, Eudocia, Batchelor, Tracy, Chiocca, E Antonio, Meredith, David, Santagata, Sandro, Reardon, David, Beroukhim, Rameen, Bi, Wenya Linda, Ligon, Keith, Wen, Patrick
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Molecular Pathology & Classification
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650887/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.685
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi